Semmelweis Egyetem 2

Budapest 1083

1 studies enrolling now · 2 studies all time

What they study most

Crohn Disease, Fistulizing Crohns Disease, Perianal Crohns Disease

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease — Running, not enrolling